Whipple's disease medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Antimicrobial therapy is indicated in Whipple's disease. Some patients may require long-term therapy. | |||
==Medical Therapy== | ==Medical Therapy== | ||
Revision as of 17:12, 14 August 2015
|
Whipple's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Whipple's disease medical therapy On the Web |
|
American Roentgen Ray Society Images of Whipple's disease medical therapy |
|
Risk calculators and risk factors for Whipple's disease medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Antimicrobial therapy is indicated in Whipple's disease. Some patients may require long-term therapy.
Medical Therapy
- 1. Initial Parenteral Therapy[1]
- Preferred regimen: Ceftriaxone 2 g IV daily for 2 weeks
- 2. Long-term Therapy[2]
- Preferred regimen: Trimethoprim-sulfamethoxazole 160/800 mg PO bid for at least 1 year
- Alternative regimen: Doxycycline 100 mg PO bid AND Hydroxychloroquine 200 mg PO tid in cases of allergy or relapse.
References
- ↑ Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455748013.
- ↑ Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455748013.